Introduction

Leading pharmaceutical company signed a share purchase agreement to acquire a generic formulations manufacturer near Vadodara. The transaction values the target at about ₹91 crore and will complete in two tranches.

Also Read: Wipro expands partnership with Google Cloud to launch Gemini Experience Zone in Bengaluru

Share price movement of Senores Pharmaceuticals

On December 16, 2025, Senores Pharmaceuticals Ltd opened at ₹844.00, up 3.49% from its previous close of ₹815.55. The stock touched a high of ₹844.00 (3.49%) and a low of ₹810.00 (−0.68%). By 12:30 PM, it traded at ₹816.90, a 0.17% increase, with a market cap of ₹3,762.12 crore.

Senores Pharma to Acquire Apnar Pharma

Senores Pharmaceuticals Limited approved acquisition of Apnar Pharma Private Limited through a share purchase agreement dated December 15, 2025. The deal involves acquisition of 100 percent equity in two tranches.

Apnar Pharma Private Limited is a pharmaceutical company manufacturing generic formulations. It operates a US FDA, UK MHRA, and Health Canada approved facility near Vadodara, Gujarat.

The acquisition values Apnar Pharma at about ₹91 crore enterprise value. The transaction includes cash payment and assumption of debt, with completion planned by March 2026 and Q2 FY2027.

Stock performance of Senores Pharmaceuticals for Period of 1 week, 1 month, and 6 months

Senores Pharmaceuticals Ltd delivered a 5.77% gain over the past week and rose 4.47% over the past month. The stock advanced 57.2% in the past six months.

Also Read: BEL stock gains after securing additional orders worth ₹776 Cr

Shareholding pattern of Senores Pharmaceuticals

Particulars	Sep 2025	Jun 2025	Mar 2025
Promoter	45.80%	45.80%	45.80%
FII	4%	4%	4%
DII	8.60%	9.50%	10%
Public	41.30%	41.00%	40.40%

About Senores Pharmaceuticals

Senores Pharmaceuticals Ltd (NSE: SENORES), incorporated in 2015, is a research-driven company manufacturing affordable, high-quality generics, specialty pharmaceuticals, critical care injectables, and APIs for regulated and emerging markets globally.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs